1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CCNB1 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA CABP7 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA AMH CTRPv2 pan-cancer AAC 0.12 0.001
mRNA IGSF9B CTRPv2 pan-cancer AAC 0.12 0.001
mRNA SYT5 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA INSIG2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA USP30 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA RP11-295P9.13 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA TDP1 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA PRKAR2A CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV